POLISCOPE
Back to bills
Part ofHealthcare →

The civic record

Read. Follow. Verify.
HB 390UTAHSession 2026State BillSigned into law
Enacted

Utah Authorizes Huntsman Mental Health Institute to Study Psychedelic Therapy for Veterans with PTSD

Original title: Veterans PTSD Clinical Research Amendments

Last action · March 19, 2026: Governor SignedSponsors: Jen Dailey-Provost and 18 others

Bill progressHistory & official text ↓
Introduced
Committee
Floor Vote
Passed
Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Public stanceCommunity reactions are separate from the official record and reporting.

What This Bill Does

The Huntsman Mental Health Institute is authorized to conduct a clinical study on the safety and feasibility of psychedelic-assisted therapy for veterans suffering from treatment-resistant post-traumatic stress disorder, funded by legislative appropriations and private donations. The institute must begin the study no later than January 1, 2027, provided sufficient funding is secured, and must eventually submit a final report to the Health and Human Services Interim Committee.

Why it matters

Eligible veterans with treatment-resistant post-traumatic stress disorder gain access to a specialized clinical research program testing controlled substances like MDMA and psilocybin, while the institute must return any unused donations by July 1, 2032.

Background
  • The Huntsman Mental Health Institute is a prominent psychiatric and mental health research and treatment facility operating within the University of Utah. context
  • State legislatures across the country have increasingly explored authorizing clinical trials and research into psychedelic compounds for mental health conditions such as post-traumatic stress disorder. context

Who It Affects

Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.

Directly affected

Huntsman Mental Health Institute

The institute is authorized and required to conduct the clinical study, maintain strict regulatory compliance, accept donations, and report findings to the Legislature.

Directly affected

Veterans with treatment-resistant PTSD

Eligible veterans gain the opportunity to participate in a regulated clinical research study testing psychedelic-assisted therapy interventions.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

Who is eligible to participate in the psychedelic-assisted therapy study?
Veterans who have a clinical diagnosis of with a documented inadequate response to one or more evidence-based treatments are eligible.
What specific drugs are authorized for use in the clinical study?
Authorized substances include 3,4-Methylenedioxymethamphetamine (MDMA), 5-methoxy-N,N-dimethyltryptamine, and Psilocybin.
How is the clinical study funded?
The study is funded through legislative appropriations and gifts, grants, or donations accepted by the Huntsman Mental Health Institute.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Follow the record

Votes, people, money & the original source

Where This Stands

Current status: Signed into law.

Procedural history

46 actions
  1. Mar 19, 2026Lieutenant Governor's office for filingEnrolled
    Governor Signed
  2. Mar 16, 2026House
    House/ to Governor
  3. Mar 16, 2026House
    House/ received enrolled bill from Printing
  4. Mar 11, 2026House
    House/ enrolled bill to Printing
  5. Mar 11, 2026Clerk of the House
    Enrolled Bill Returned to House or Senate
  6. Mar 10, 2026Legislative Research and General Counsel / Enrolling
    Draft of Enrolled Bill Prepared
Show 40 earlier actions
  1. Mar 10, 2026Legislative Research and General Counsel / Enrolling
    Bill Received from House for Enrolling
  2. Mar 4, 2026House
    House/ signed by Speaker/ sent for enrolling
  3. Mar 4, 2026House
    House/ received from Senate
  4. Mar 4, 2026Senate
    Senate/ to House
  5. Mar 4, 2026Senate
    Senate/ signed by President/ returned to House
  6. Mar 4, 2026SenateFloor
    Senate/ passed 2nd & 3rd readings/ suspension
  7. Mar 3, 2026Senate
    Senate/ placed on 2nd Reading Calendar
  8. Feb 26, 2026Senate
    Senate/ placed on 3rd Reading Calendar table
  9. Feb 26, 2026Senate
    Senate/ 3rd reading
  10. Feb 26, 2026SenateFloor
    Senate/ passed 2nd reading
  11. Feb 26, 2026Senate
    Senate/ uncircled
  12. Feb 26, 2026Senate
    Senate/ circled
  13. Feb 26, 2026Senate
    Senate/ 2nd & 3rd readings/ suspension
  14. Feb 25, 2026Senate
    Senate/ placed on 2nd Reading Calendar
  15. Feb 25, 2026Senate
    Senate/ committee report favorable
  16. Feb 24, 2026Senate
    Senate Comm - Favorable Recommendation
  17. Feb 20, 2026SenateCommittee
    Senate/ to standing committee
  18. Feb 19, 2026SenateIntroduced
    Senate/ 1st reading (Introduced)
  19. Feb 18, 2026Senate
    Senate/ received from House
  20. Feb 18, 2026House
    House/ to Senate
  21. Feb 18, 2026HouseFloor
    House/ passed 3rd reading
  22. Feb 18, 2026House
    House/ 3rd reading
  23. Feb 10, 2026Released
    LFA/ fiscal note publicly available for HB0390S01
  24. Feb 10, 2026Version Sponsor
    LFA/ fiscal note sent to sponsor for HB0390S01
  25. Feb 10, 2026House
    House/ 2nd reading
  26. Feb 10, 2026House
    House/ comm rpt/ substituted
  27. Feb 9, 2026House
    House Comm - Favorable Recommendation
  28. Feb 9, 2026House
    House Comm - Substitute Recommendation
  29. Feb 9, 2026Legislative Fiscal Agency
    LFA/ bill sent to agencies for fiscal input for HB0390S01
  30. Feb 9, 2026Legislative Fiscal Analyst
    LFA/ bill assigned to staff for fiscal analysis for HB0390S01
  31. Feb 5, 2026HouseCommittee
    House/ to standing committee
  32. Jan 30, 2026House
    House/ received fiscal note from Fiscal Analyst
  33. Jan 29, 2026Released
    LFA/ fiscal note publicly available for HB0390
  34. Jan 29, 2026Version Sponsor
    LFA/ fiscal note sent to sponsor for HB0390
  35. Jan 27, 2026HouseIntroduced
    House/ 1st reading (Introduced)
  36. Jan 27, 2026House
    House/ received bill from Legislative Research
  37. Jan 26, 2026Legislative Fiscal Agency
    LFA/ bill sent to agencies for fiscal input for HB0390
  38. Jan 26, 2026Legislative Fiscal Analyst
    LFA/ bill assigned to staff for fiscal analysis for HB0390
  39. Jan 26, 2026Legislative Research and General Counsel
    Numbered Bill Publicly Distributed
  40. Jan 26, 2026Legislative Research and General Counsel
    Bill Numbered but not Distributed

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Lobbying Activity

No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Sponsors

Jen Dailey-ProvostHouse · District 22DemocraticPrimary sponsor
Nelson AbbottHouse · District 57RepublicanCosponsor
John ArthurHouse · District 41DemocraticCosponsor
Burton, J.HouseCosponsorNo profile match
Rosalba DominguezHouse · District 35DemocraticCosponsor
Show 14 more sponsors
Jake FitisemanuHouse · District 30DemocraticCosponsor
Sahara HayesHouse · District 32DemocraticCosponsor
Sandra HollinsHouse · District 21DemocraticCosponsor
Trevor LeeHouse · District 16RepublicanCosponsor
Ashlee MatthewsHouse · District 37DemocraticCosponsor
Verona MaugaHouse · District 31DemocraticCosponsor
Grant MillerHouse · District 24DemocraticCosponsor
Carol MossHouse · District 34DemocraticCosponsor
Hoang NguyenHouse · District 23DemocraticCosponsor
Doug OwensHouse · District 33DemocraticCosponsor
Angela RomeroHouse · District 25DemocraticCosponsor
Jake SawyerHouse · District 9RepublicanCosponsor
Andrew StoddardHouse · District 40DemocraticCosponsor
Kirk CullimoreSenate · District 19RepublicanCosponsor

Discoveries

1 pattern noticed across the record

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift95% confidence

State-Authorized Psychedelic Research

The legislation establishes a specific statutory framework enabling a state university medical institute to research controlled substances traditionally classified under strict federal restrictions.

Huntsman Mental Health InstituteUnited States Food and Drug Administration

Connected Entities

United States Drug Enforcement Agency, Health and Human Services Interim Committee, University of Utah and 2 more
OrganizationUnited States Drug Enforcement Agency“Federal agency requiring Schedule I research registration.”Map →
OrganizationHealth and Human Services Interim Committee“Legislative committee designated to receive progress reports and the final study”Map →
OrganizationUniversity of Utah“Parent university housing the Huntsman Mental Health Institute.”Map →
OrganizationUnited States Food and Drug Administration“Federal agency authorizing investigational new drugs for human subjects research”Map →
OrganizationHuntsman Mental Health Institute“Mental health and substance use treatment institute within the University of Uta”Map →

Sources

Open source document

le.utah.gov

Analysis Score

0–100
  • Significance65
    How much this matters to a regular citizen
  • Controversy50
    Intensity of disagreement among stakeholders
  • Entertainment10
    Compellingness for a non-policy-wonk reader
  • Buzz45
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record